With this context and industry outlook in mind, let's start our list of 10 best biotech stocks to buy for 2021.
Drug-Pricing Concerns
The ever-present worry of drug-pricing reform continues to weigh on biotech stocks. ... "A lot of people are blaming this as the primary factor (for falling biotech stocks)," Loncar said.
XBIT, BDSI, and ACRS are top for value, growth, and momentum, respectively. The biotechnology industry includes companies that develop drugs and diagnostic technologies for the treatment of diseases and medical conditions.
Four great pharmaceutical stocks
Jeff Bezos-backed startup Nautilus Biotechnology set to go public via SPAC at $900M valuation. Nautilus Biotechnology, a Seattle-based biotech startup led by Isilon co-founder Sujal Patel, is the latest company to go public using a special purpose acquisition company, or SPAC.
Warren Buffett's Berkshire Hathaway has bought 648,447 shares of Biogen at a combined worth of $192.4 million ahead of the FDA filing of a controversial Alzheimer's drug.
Biotech stocks are high-risk, high-reward investments. March 12, 2021, at 3:22 p.m. Analysts love these biotech stocks in 2021. Small- and mid-cap biotech stocks are among the most high-risk, high-reward stocks in the market.
Gainers
| Company | Price | % Change |
|---|---|---|
| DVN Devon Energy Corp | 24.03 | +8.54% |
| HES Hess Corp | 75.94 | +7.79% |
| MRO Marathon Oil Corp | 11.75 | +6.43% |
| SYF Synchrony Financial | 43.03 | +5.65% |
Pfizer (NYSE:PFE) is a buy at current prices. Specifically, at around $35 per share, PFE stock offers investors a fair price, solid dividends and opportunity for growth.
Yet No Comments